We are excited to announce that CardiaMetrics has successfully completed its first funding round, raising €300,000 from private investors and leading cardiologists. These investors recognized the unique value in our solution, which bridges the gap between non-invasive telemonitoring technologies and implantable pressure sensors, whose medical-economic performance has not yet justified reimbursement.
This funding will enable us to accelerate the development of our technology through strategic recruitments and the preparation of our first clinical studies in collaboration with the Caen University Hospital (CHU de Caen). These studies will be a crucial step in validating the clinical safety and launch our AI strategy, further strengthening its position in the cardiac telemonitoring market.
Stay tuned for further updates as we continue to advance in the field of cardiac health management.